Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

06 Jun 2016 - 09 Jun 2016
22 Jun 2016 - 24 Jun 2016
04 Jul 2016 - 06 Jul 2016

Stem Cell Development Could Lead to New Nanoscale Bone Repair Technology

By BiotechDaily International staff writers
Posted on 27 Feb 2013
Print article
Image: Stem cell breakthrough could lead to new bone repair therapies (Photo courtesy of the University of Southampton).
Image: Stem cell breakthrough could lead to new bone repair therapies (Photo courtesy of the University of Southampton).
British scientists have created a new application to help generate bone cells that could lead to groundbreaking bone repair therapies for individuals with bone fractures or those who need hip replacement surgery due to osteoporosis and osteoarthritis.

The research, performed by Dr. Emmajayne Kingham, from the University of Southampton (UK), working with colleagues the University of Glasgow (Scotland, UK), and published online January 30, 2013, in the journal Small, cultured human embryonic stem cells on to the surface of plastic materials and evaluated their capability to change.

Scientists were able to use the nanotopographic patterns on the biomedical plastic to manipulate human embryonic stem cells towards bone cells. This was accomplished without any chemical enhancement. The compounds, including the biomedical implantable substance polycarbonate plastic, provide an available and less expensive way of culturing human embryonic stem cells and presents new avenues for future medical research in this field.

Prof. Richard Oreffo, who led the University of Southampton team, explained, “To generate bone cells for regenerative medicine and further medical research remains a significant challenge. However, we have found that by harnessing surface technologies that allow the generation and ultimately scale up of human embryonic stem cells to skeletal cells, we can aid the tissue engineering process. This is very exciting. Our research may offer a whole new approach to skeletal regenerative medicine. The use of nanotopographical patterns could enable new cell culture designs, new device designs, and could herald the development of new bone repair therapies as well as further human stem cell research.”

This latest discovery expands on the close collaborative research earlier undertaken by the University of Southampton and the University of Glasgow. In 2011, the scientists effectively used plastic with embossed nanopatterns to cultivate and spread adult stem cells while maintaining their stem cell properties, a process that is less expensive and simpler to produce than earlier ways of manufacturing.

Dr. Nikolaj Gadegaard, Institute of Molecular, Cell and Systems Biology at the University of Glasgow, remarked, “Our previous collaborative research showed exciting new ways to control mesenchymal stem cell--stem cells from the bone marrow of adults—growth and differentiation on nanoscale patterns. This new Southampton-led discovery shows a totally different stem cell source, embryonic, also respond in a similar manner and this really starts to open this new field of discovery up. With more research impetus, it gives us the hope that we can go on to target a wider variety of degenerative conditions than we originally aspired to. This result is of fundamental significance.”

Related Links:
University of Southampton
University of Glasgow



Print article

Channels

Genomics/Proteomics

view channel
Image: A dark field photomicrograph showing the spirochete bacterium Borrelia burgdorferi, the pathogen responsible for causing Lyme disease (Photo courtesy of the CDC).

Statins May Help Block Transmission of Lyme Disease

A recent study found that treatment with cholesterol-lowering statins reduced the number of Borrelia burgdorferi bacteria in rodents, which helped to block transmission of Lyme disease. Lyme disease... Read more

Drug Discovery

view channel

Experimental Small-Molecule Anticancer Drug Blocks RAS-binding Domains

The experimental small-molecule anticancer drug rigosertib was shown to block tumor growth by acting as an RAS-mimetic and interacting with the RAS binding domains of RAF kinases, resulting in their inability to bind to RAS, which inhibited the RAS-RAF-MEK pathway. Oncogenic activation of RAS genes due to point mutations... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Business

view channel

European Biotech Agreement to Promote Antigen-Drug Conjugation Technology

Two European biotech companies have joined forces to exploit and commercialize an innovative, site-specific ADC (antigen-drug conjugate) conjugation technology. ProBioGen (Berlin, Germany), a company specializing in the development and manufacture of complex glycoproteins and Eucodis Bioscience (Vienna, Austria), a... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.